JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RXRX - Recursion Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary RXRX Stock
Financials
Financials RXRX Stock
Loading...
Loading...
Income Statement
Income Statement RXRX Stock
Balance Sheet
Balance Sheet RXRX Stock
Cash Flow Statement
Cash Flow Statement RXRX Stock
Loading...
Loading...
RXRX Financials - Recursion Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Recursion Pharmaceuticals, Inc. (RXRX)
Financials
Financials of RXRX
Loading...
Loading...
Loading...
Loading...
Revenue
$74.681M
Operating Income
$-648.132M
Net Income
$-644.759M
Share Count (Basic)
447.446109M
Operating Cash Flow
$-371.808M
Free Cash Flow
$-378.277M
Cash And Short-Term Equivalents
$743.294M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-600M
-500M
-400M
-300M
-200M
Annual
Quarterly
Margins
Gross
Operating
Net
-2000%
-1500%
-1000%
-500%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-200M
-180M
-160M
-140M
-120M
-100M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26